Journal of Hematology & Oncology

Table 3 Multivariate analysis for overall survival (OS) and progression-free survival (PFS)

From: Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation

Variable	OS			PFS
	HR	95 % CI	p	HR	95 % CI	p
A-ALC ≥ 0.5 × 10⁹/kg	0.401	0.231–0.972	0.04	0.439	0.271–0.902	0.03
A-AMC < 0.6 × 10⁹/kg	0.502	0.100–0.985	0.04	0.490	0.288–0.911	0.03
A-LMR ≥ 1	0.258	0.105–0.561	<0.001	0.298	0.112–0.482	<0.001
CR prior to APHSCT	0.356	0.166–0.731	0.005	0.401	0.211–0.681	0.008
Hemoglobin < 12 g/dl				1.592	0.861–2.935	0.1
IPI > 2	2.377	1.163–4.972	0.02	1.398	0.705–2.771	0.3
Platelet < 150 × 10⁹/l	1.297	0.627–2.607	0.5	1.164	0.590–2.268	0.7

Abbreviations: A-ALC autograft absolute lymphocyte count, A-AMC autograft absolute monocyte count, A-LMR autograft lymphocyte/monocyte ratio, A-LMR autograft lymphocyte/monocyte ratio, CR complete response, IPI International Prognostic Index, LDH lactate dehydrogenase

Back to article page

ISSN: 1756-8722

Contact us

General enquiries: journalsubmissions@springernature.com